MENUNews Archive
Date: 06/07/2018
Media contact: Jessica Webster-Sendra, 734-764-2220 | Patients may contact Cancer AnswerLine, 800-865-1125
Date: 06/06/2018
A new study shows how to personalize the lung cancer screening decision for every patient. The results could help doctors fine-tune their advice to patients so that it’s based not only on a patient’s individual lung cancer risk and the potential benefits and harms of screening, but also the patient’s attitude about looking for problems and dealing with the consequences.
Date: 05/20/2018
Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Clinical Oncology (ASCO) Annual meeting from Friday, June 1 through Tuesday, June 5. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.
Date: 05/15/2018
The outside of a cancer cell is bombarded by signals. They come from the immune system, supporting tissues, and other structures. But how do those signals affect cancer? A new study provides a surprising model of the process by which those signals enter and influence the cell. The finding could open up a potential new avenue to pursue new therapies against cancer.
Date: 05/09/2018
Although it is rare, knowledge of this risk is important both for the ophthalmologists who treat it and for the oncologists prescribing the anti-cancer treatment, say Michigan Medicine researchers. The cases of three recent patients, published in JAMA Ophthalmology, highlight the issue. Patients receiving immune checkpoint inhibitors developed uveal effusions and eye inflammation that affected their vision.
Date: 05/09/2018
Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Cancer Oncology (ASCO) Annual meeting from Friday, June 1 through Tuesday, June 5. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.
Date: 05/01/2018
In the first large, randomized trial to look at immunotherapy as a first-line cancer treatment, researchers found that adding the immunotherapy drug pembrolizumab to chemotherapy for advanced lung cancer led to better tumor control and overall survival than chemotherapy followed by pembrolizumab.
Date: 04/30/2018
As many as one in three women treated for breast cancer undergo unnecessary procedures, which is why it's important to find new ways to diagnose the disease. Research in mice finds a special kind of pill could do a better job distinguishing between benign and aggressive tumors.
Date: 04/10/2018
Researchers from the University of Michigan Rogel Cancer Center will attend the American Assocation for Cancer Research Annual meeting from Sunday, April 14 through Wednesday, April 18. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.
Date: 04/09/2018
Thirteen years after its initial funding, The Cancer Genome Atlas (TCGA) has analyzed 2.5 petabytes of data representing 33 different types of cancer. A series of 27 papers publishing across the Cell Press family of journals summarizes its final project, PanCancerAtlas, the most comprehensive cross-cancer genomic analysis available.